HealthEquity, Inc. (NASDAQ:HQY) Shares Purchased by Geode Capital Management LLC

Geode Capital Management LLC boosted its position in HealthEquity, Inc. (NASDAQ:HQY) by 0.7% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,078,977 shares of the company’s stock after acquiring an additional 15,145 shares during the period. Geode Capital Management LLC owned about 2.38% of HealthEquity worth $170,197,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Wasatch Advisors LP grew its holdings in HealthEquity by 6.6% in the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after purchasing an additional 483,269 shares during the period. Mackenzie Financial Corp boosted its holdings in shares of HealthEquity by 16.0% in the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after purchasing an additional 325,906 shares during the last quarter. Generate Investment Management Ltd purchased a new stake in shares of HealthEquity during the 2nd quarter valued at $24,184,000. Vaughan Nelson Investment Management L.P. increased its holdings in shares of HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after buying an additional 226,563 shares during the last quarter. Finally, Thrivent Financial for Lutherans raised its position in shares of HealthEquity by 924.2% in the 2nd quarter. Thrivent Financial for Lutherans now owns 220,220 shares of the company’s stock worth $18,983,000 after buying an additional 198,718 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Stock Performance

HealthEquity stock opened at $95.62 on Monday. The company has a current ratio of 3.20, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock has a 50 day moving average of $94.06 and a 200-day moving average of $84.26. The stock has a market cap of $8.29 billion, a P/E ratio of 87.72, a price-to-earnings-growth ratio of 1.10 and a beta of 0.55. HealthEquity, Inc. has a 52 week low of $62.10 and a 52 week high of $105.82.

Analyst Ratings Changes

A number of equities research analysts have issued reports on HQY shares. Barrington Research boosted their price target on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. The Goldman Sachs Group initiated coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price for the company. Deutsche Bank Aktiengesellschaft lifted their price target on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Royal Bank of Canada boosted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Finally, Mizuho began coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now owns 3,784 shares of the company’s stock, valued at $363,642.40. This trade represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,786 shares of company stock worth $4,140,387 over the last quarter. 2.20% of the stock is owned by corporate insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.